Advanced Search

 

Study ID Status Title Patient Level Data
FNA40001 Completed A Multicentre, Randomised, Blinded, Parallel-Group Comparison of nebulised Fluticasone Propionate 250?g bid with nebulised Budesonide 500?g bid in asthmatic children.
FNB30001 Completed A single centre, randomised, double blind, parallel group study to compare the efficacy of nebulised Fluticasone Propionate 2 mg twice daily (bd) with placebo in patients with moderate to severe chronic obstructive pulmonary disease.
FNB30005 Completed A multicentre, blinded, randomised, parallel group study to compare the efficacy and tolerability of nebulised fluticasone propionate 0.25mg bid versus nebulised beclomethasone dipropionate 0.40mg bid in children suffering from acute inflammatory conditions of the upper airways
FNLN44 Completed A single-centre, randomised, double-blind, parallel group study to determine the efficacy and tolerability of fluticasone propionate aqueous nasal spray 100 mcg four times daily, fluticasone propionate aqueous nasal spray 200 mcg four times daily and placebo aqueous nasal spray four times daily…
FNM10001 Completed The Systemic Pharmacodynamics and Pharmacokinetics of Intranasal Fluticasone Propionate and Intranasal Mometasone Furoate Administered via an Aqueous Nasal Spray in Healthy Subjects
FNM10003 Completed An open study to investigate the nasal bioavailability of intra-nasally administered fluticasone propionate administered as a solution formulation, HFA nasal MDI formulation and as the aqueous nasal spray during charcoal block in healthy subjects. Study Listed on ClinicalStudyDataRequest.com
FNM10004 Completed An open, three-period, balanced, incomplete block crossover study in healthy subjects to investigate the effect of 7 days co-administration of fluticasone propionate aqueous nasal spray (FPANS) with ritonavir, ketoconazole, or erythromycin on serum cortisol levels Study Listed on ClinicalStudyDataRequest.com
FNM30003 Completed The effect of intranasal fluticasone propionate on the recovery of proinflammatory cytokines in the nasal secretions following allergen challenge
FNM30006 Completed A double-blind, randomized, parallel group, multicenter, placebo-controlled clinical trial to evaluate the safety and efficacy of once-daily versus twice-daily intranasal administration of aqueous fluticasone propionate versus aqueous beclomethasone dipropionate in patients with perennial allerg ...
FNM30007 Completed A double-blind, randomized, parallel group, mutlicenter, placebo-controlled clinical trial to evaluate the safety and efficacy of once-daily versus twice-daily intranasal administration of aqueous fluticasone propionate in patients with perennial allergic rhinitis.
FNM30008 Completed A double-blind, randomized, placebo-controlled study of the efficacy and safety of aqueous fluticasone propionate versus placebo for four weeks in pediatric patients with seasonal allergic rhinitis.
FNM30015 Completed A dose-ranging, parallel-group study comparing fluticasone propionate aqueous nasal spray 50mcg, 100mcg, 200mcg and 400mcg twice daily with placebo in patients with perennial rhinitis.
FNM30016 Completed A single-centre, randomised, double-blind, parallel group study to determine the efficacy and tolerability of fluticasone propionate aqueous nasal spray 200µg twice daily, beclomethasone dipropionate aqueous nasal spray 200µg twice daily and placebo aqueous nasal spray administered twice daily i ...
FNM30019 Completed Fluticasone propionate aqueous nasal spray 200mcg once daily vs. 100mcg twice daily in ragweed allergic rhinitis in a multicentre, double-blind, placebo-controlled, parallel group study.
FNM30020 Completed A double-blind, placebo-controlled, parallel group comparative study to assess the safety and efficacy of fluticasone propionate aqueous nasal spray, 200mcg given once daily, with beclomethasone dipropionate aqueous nasal spray, 200mcg given twice daily, in the treatment of seasonal rhinitis.
FNM30021 Completed A double-blind, parallel-group study to assess the safety of long-term use of fluticasone propionate aqueous nasal spray (200mcg given twice daily) compared with beclomethasone dipropionate aqueous nasal spray (200mcg given twice daily) in the treatment of perennial rhinitis.
FNM30024 Completed Fluticasone propionate aqueous nasal spray, 200mcg twice daily, versus beclomethasone dipropionate aqueous nasal spray, 200mcg twice daily, in seasonal rhinitis. A multicentre, placebo-controlled, double-blind, parallel-group study.
FNM30029 Completed A parallel group comparison of fluticasone propionate aqueous nasal spray (FPANS) with placebo in patients with non-seasonal allergic rhinitis with symptoms all year round.
FNM30030 Completed A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
FNM30031 Completed A Double-Blind, Double-Dummy, Randomized, Parallel Group Comparison of 200mcg Fluticasone Propionate Aqueous Nasal Spray, Placebo and 10mg Encapsulated Loratadine Administered (No More than Once Daily) As-Needed in Subjects with Seasonal Allergic Rhinitis
FNM30033 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Systems Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM30034 Completed A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy of a Four-Week Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) on Ocular Symptoms Commonly Associated with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40001 Completed A multi-centre, randomised, double blind, placebo controlled, parallel group study examining the effect of fluticasone propionate aqueous nasal spray (200mcg od) and/or inhaled fluticasone propionate (250mcg bd) in pollen induced asthma and rhinits.
FNM40017 Completed A Multi-Center, Randomized, Double-Blind, Parallel Gruop Study to Assess the Potential Growth Effects of a One-year Course of Fluticasone Propionate Aqueous Nasal Spray (200mcg QD) versus Placebo in Pre-pubescent, Pediatric Subjects with Perennial Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
FNM40027 Completed Intranasal fluticasone propionate 200?g once daily versus 200?g twice daily in severe ragweed allergic rhinitis.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.